Coloplast A/S (CLPBY) to Release Earnings on Friday

Coloplast A/S (OTCMKTS:CLPBY) is anticipated to announce its results before the market opens on Friday, February 6th. Analysts expect the company to announce earnings of $0.09 per share for the quarter.

Coloplast A/S (OTCMKTS:CLPBY) last posted its earnings results on Tuesday, November 4th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.02). Coloplast A/S had a return on equity of 24.99% and a net margin of 13.01%.The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.10 billion. On average, analysts expect Coloplast A/S to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Coloplast A/S Trading Up 1.4%

Shares of OTCMKTS CLPBY opened at $8.60 on Friday. The company has a current ratio of 1.61, a quick ratio of 1.00 and a debt-to-equity ratio of 1.20. The company has a market cap of $19.38 billion, a PE ratio of 35.83, a P/E/G ratio of 0.81 and a beta of 0.26. The company has a 50-day moving average of $8.74 and a two-hundred day moving average of $9.13. Coloplast A/S has a 1-year low of $8.34 and a 1-year high of $11.73.

Analyst Upgrades and Downgrades

Separately, Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a report on Wednesday. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Coloplast A/S currently has an average rating of “Hold”.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.